Jacobio Pharmaceuticals Group Co., Ltd. (01167) disclosed that on 17 October 2025, 135,000 ordinary shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 7.30 to HKD 7.35 per share, with a total consideration of HKD 989,577. The repurchased shares were added to treasury shares, raising the treasury total to 3,481,200 shares.

Following this transaction, the number of issued shares excluding treasury shares is 788,273,880, while the overall total remains at 791,755,080 shares. The repurchase was conducted under a mandate granted on 10 June 2025, which authorizes the repurchase of up to 78,873,528 shares. As of the repurchase date, 461,400 shares in total have been repurchased under this mandate, representing approximately 0.0585% of the then-issued shares. A moratorium on new share issuance or treasury share disposal is in effect until 16 November 2025.